查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1768802

全球生物淨化市場

Bio Decontamination
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 177 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計到 2030 年全球生物淨化市場規模將達到 2.688 億美元

全球生物淨化市場規模預計在2024年為2.06億美元，到2030年將達到2.688億美元，2024年至2030年的複合年成長率為4.5%。設備是本報告分析的細分市場之一，預計複合年成長率為4.2%，到分析期結束時將達到1.221億美元。服務細分市場在分析期間內的複合年成長率預計為5.1%。

美國市場規模估計為 5,620 萬美元，中國市場預計複合年成長率為 4.3%

預計2024年，美國生物淨化市場規模將達5,620萬美元。作為世界第二大經濟體，中國市場規模預計到2030年將達到4,230萬美元，在2024-2030年的分析期間內，複合年成長率為4.3%。其他值得關注的區域市場包括日本和加拿大，預計在分析期間內，這兩個市場的複合年成長率分別為4.2%和3.5%。在歐洲，預計德國市場的複合年成長率為3.7%。

全球生物淨化市場－主要趨勢與促進因素摘要

為什麼生物淨化在當今世界至關重要？

在當今世界，人們對生物污染風險的認知顯著提高，生物淨化已成為醫療保健、製藥、食品加工和公共場所等各行各業的關鍵業務。生物淨化涉及從表面、空氣和設備中去除或去活化有害病原體，例如細菌、病毒、真菌和孢子，以降低感染風險，防止污染，並確保產品和人員的安全。例如，在醫療保健環境中，嚴格的生物淨化對於防止醫院內感染 (HAI) 的傳播至關重要，這種感染每年影響數百萬患者，並構成嚴重的健康風險。同樣，製藥公司和實驗室中的污染，即使是微量污染，也可能威脅產品品質、研究結果和法規遵從性，凸顯了嚴格淨化通訊協定的重要性。 COVID-19 疫情進一步凸顯了生物淨化的必要性，世界各地的組織都在尋求可靠的方法對高頻接觸表面進行消毒，以確保員工和客戶的安全。隨著人們對感染疾病控制和衛生標準認知的不斷提高，生物淨化已成為許多行業維持安全、衛生和合規環境的必要條件——最終成為我們日益互聯的空間中公共健康和安全的基石。

哪些新興技術正在影響生物淨化？

近年來，科技進步徹底改變了生物淨化工藝，催生了各種創新方法，使淨化過程更快、更有效、更環保。其中最具突破性的創新之一是汽化過氧化氫 (VHP) 淨化技術的開發，它透過將過氧化氫蒸氣擴散到密閉迴路境中來殺滅多種病原體。這種方法非常有效，因為它能夠穿透難以觸及的區域，使複雜的表面和精密的設備能夠完全消毒，且不留下有害殘留物。紫外線 (UV-C) 光技術也得到了廣泛應用，它提供了一種快速、無化學物質的表面和空氣淨化方法，特別適用於醫院、實驗室和人流量大的公共區域。隨著 UV-C 系統越來越可攜式且經濟高效，它們正部署到從暖通空調系統到公共交通等各種環境中。機器人和自動化技術進一步增強了這些技術，使其能夠實現精準一致的應用，減少對人工的依賴，最大限度地降低出錯的可能性，並全面覆蓋受污染的空間。臭氧淨化和離子化過氧化氫等其他技術因其能夠有效淨化大面積開放區域和空氣處理系統而日益普及。這些技術進步正在將生物淨化轉變為更快速、更安全、更靈活的過程，幫助各行各業維持嚴格的衛生標準，並降低病原體傳播的風險。

企業在實施生物淨化時面臨哪些挑戰？

儘管生物淨化具有明顯的優勢，但其實施也面臨重大挑戰，尤其是在業務中斷、法規遵循和成本管理方面。許多淨化方法，例如氣化熱處理 (VHP)，需要在淨化過程中暫時關閉並密閉設施，以確保最佳的蒸氣濃度和有效性。在需要持續運作的環境中，例如醫院和製造工廠，這種停機時間尤其具有挑戰性。此外，遵守嚴格的安全和環境法規至關重要。某些淨化化學品如果使用和處置不當，可能會對工人的健康構成風險，並對環境造成負面影響。醫療保健、製藥和食品加工等行業受到嚴格監管，FDA、EPA 和 OSHA 等機構監督淨化通訊協定和工人安全，因此法規遵循是實施過程中不可或缺的環節。此外，對於規模較小的組織來說，先進的淨化技術和程序的成本可能是一個重大障礙，因為在專用設備、員工培訓和基礎設施調整方面需要大量的初始投資。此外，針對特定環境選擇合適的淨化方法需要仔細考慮各種因素，例如目標病原體、設施佈局以及待處理表面的性質，這又增加了一層複雜性。這些挑戰意味著，企業在實施生物淨化流程時必須投入策略規劃和專家指導，以有效滿足業務、安全和監管要求。

推動生物淨化市場成長的關鍵因素有哪些？

生物淨化市場正經歷強勁成長，這得益於人們日益增強的感染預防意識、不斷變化的監管要求以及快速的技術進步，這些技術使淨化更加高效便捷。尤其是在醫療保健環境中，對感染控制的重視催生了對旨在最大程度減少醫院內感染 (HAI) 和其他感染疾病傳播的綜合淨化解決方案的巨大需求。處理敏感產品和數據的行業，例如製藥、生物技術和食品加工，尤其需要成熟的淨化方法，以確保合規性並維護產品完整性。此外，VHP、UV-C 紫外線和機器人系統等技術進步使生物淨化更快、更安全。這些創新提供了可適應不同環境和營運限制的有效解決方案。包括 COVID-19 疫情在內的感染疾病疫情凸顯了公共場所生物淨化的重要性，導致交通運輸、餐旅服務業、零售和政府機構等行業的需求增加。消費者對衛生和安全意識的提高，使得人們越來越青睞那些重視生物淨化的公司，這進一步推動了市場擴張。這些促進因素共同推動了生物去污市場向前發展，使生物去污在全球各行各業維護衛生、安全和法規遵從的努力中發揮關鍵作用。

部分

產品與服務（設備、服務、耗材）；最終用戶（製藥與醫療設備公司、生命科學與生物技術研究機構、醫院與醫療機構）

受訪公司範例

  • Amira Srl
  • ClorDiSys Solutions, Inc.
  • Ecolab
  • Fedegari Autoclavi SpA
  • Howorth Air Technology Ltd.
  • JCE Biotechnology
  • Noxilizer, Inc.
  • STERIS PLC
  • TOMI Environmental Solutions Inc.
  • Wenzhou Weike Biological Laboratory Equipment Co. Ltd.

人工智慧整合

全球產業分析師正在利用可操作的專家內容和人工智慧工具改變市場和競爭情報。

Global Industry Analysts 並未遵循典型的 LLM 或特定產業的 SLM查詢，而是建立了一個從全球專家收集的內容庫，其中包括影片錄影、部落格、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地、進出口狀況（成品和原始OEM）預測其競爭態勢的變化。這種複雜且多面向的市場動態預計將以多種方式影響競爭對手，包括銷貨成本成本 (COGS) 上升、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

  • 市場概覽
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲國家
  • 亞太地區
  • 其他地區

第4章 比賽

簡介目錄
Product Code: MCP21328

Global Bio Decontamination Market to Reach US$268.8 Million by 2030

The global market for Bio Decontamination estimated at US$206.0 Million in the year 2024, is expected to reach US$268.8 Million by 2030, growing at a CAGR of 4.5% over the analysis period 2024-2030. Equipment, one of the segments analyzed in the report, is expected to record a 4.2% CAGR and reach US$122.1 Million by the end of the analysis period. Growth in the Services segment is estimated at 5.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$56.2 Million While China is Forecast to Grow at 4.3% CAGR

The Bio Decontamination market in the U.S. is estimated at US$56.2 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$42.3 Million by the year 2030 trailing a CAGR of 4.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.2% and 3.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.7% CAGR.

Global Bio Decontamination Market - Key Trends and Drivers Summarized

Why Is Bio Decontamination Essential in Today’s World?

In today’s world, bio decontamination has become a critical practice across a wide array of industries, including healthcare, pharmaceuticals, food processing, and public spaces, as the awareness of biological contamination risks has risen significantly. Bio decontamination involves the targeted removal or inactivation of harmful pathogens, such as bacteria, viruses, fungi, and spores, from surfaces, air, and equipment to reduce infection risk, prevent contamination, and ensure the safety of both products and people. In healthcare environments, for instance, rigorous bio decontamination is essential to prevent the spread of hospital-acquired infections (HAIs), which impact millions of patients annually and pose serious health risks. Similarly, in pharmaceutical manufacturing and research laboratories, contamination, even at minute levels, can compromise product quality, research outcomes, and regulatory compliance, underlining the importance of stringent decontamination protocols. The COVID-19 pandemic further highlighted the necessity of bio decontamination, as organizations worldwide sought reliable ways to sanitize high-contact areas to ensure the safety of both employees and customers. In light of the growing recognition of infection control and hygiene standards, bio decontamination has become indispensable in maintaining safe, hygienic, and compliant environments across numerous industries, ultimately serving as a cornerstone for public health and safety in increasingly interconnected spaces.

What Advanced Technologies Are Shaping Bio Decontamination?

Recent advancements in technology have revolutionized bio decontamination, offering a range of innovative methods that make the process faster, more effective, and environmentally friendly. One of the most transformative innovations has been the development of vaporized hydrogen peroxide (VHP) decontamination, which involves dispersing hydrogen peroxide vapor into a sealed environment to eliminate a broad spectrum of pathogens. This method is highly effective, as it can penetrate hard-to-reach areas, ensuring complete sterilization of complex surfaces and sensitive equipment without leaving harmful residues. Ultraviolet-C (UV-C) light technology has also become widely adopted, providing a quick, chemical-free approach to surface and air decontamination that is particularly suited for hospitals, laboratories, and high-traffic public areas. As UV-C systems become more portable and cost-effective, they are being deployed in diverse settings, from HVAC systems to public transport. Robotics and automation have further enhanced these technologies, allowing for precise, consistent application and reducing reliance on human labor, which minimizes the potential for error and ensures comprehensive coverage of contaminated spaces. Additional technologies, such as ozone decontamination and ionized hydrogen peroxide, are gaining traction for their ability to sanitize large, open areas and air handling systems effectively. Together, these technological advances are transforming bio decontamination into a faster, safer, and more adaptable process, enabling various sectors to maintain rigorous hygiene standards and reduce pathogen transmission risks.

What Challenges Do Organizations Face in Implementing Bio Decontamination?

Despite the clear benefits, implementing bio decontamination poses significant challenges, particularly related to operational disruption, regulatory compliance, and cost management. Many decontamination methods, such as VHP, require facilities to be temporarily closed off and airtight during the process to ensure optimal vapor concentration and effectiveness, which can disrupt daily operations and lead to productivity losses. This downtime can be particularly challenging in settings that require continuous operation, such as hospitals or manufacturing plants. Moreover, compliance with stringent safety and environmental regulations is crucial, as certain decontamination chemicals, if not applied and disposed of correctly, can pose health risks to personnel and have adverse environmental impacts. Industries like healthcare, pharmaceuticals, and food processing are highly regulated, with agencies like the FDA, EPA, and OSHA overseeing decontamination protocols and worker safety, making adherence to regulations a non-negotiable aspect of implementation. Additionally, the cost of advanced decontamination technologies and procedures can be a significant barrier for smaller organizations, as initial investments in specialized equipment, staff training, and infrastructure adjustments can be substantial. Choosing the appropriate decontamination method for a given environment adds another layer of complexity, requiring careful consideration of factors such as the pathogens being targeted, facility layout, and the nature of surfaces being treated. These challenges underscore the need for organizations to invest in strategic planning and expert guidance when implementing bio decontamination processes to ensure they meet operational, safety, and regulatory requirements effectively.

What Are the Key Growth Drivers in the Bio Decontamination Market?

The bio decontamination market is experiencing strong growth, fueled by rising awareness of infection prevention, evolving regulatory requirements, and rapid technological advancements that make decontamination more efficient and accessible. The emphasis on infection control, particularly in healthcare settings, has created substantial demand for comprehensive decontamination solutions designed to minimize the spread of HAIs and other infectious diseases. Regulatory agencies worldwide are enforcing stricter hygiene standards, especially for industries handling sensitive products or data, such as pharmaceuticals, biotechnology, and food processing, which are required to adopt proven decontamination methods to ensure compliance and maintain product integrity. Additionally, advancements in technologies such as VHP, UV-C light, and robotic systems are making bio decontamination faster and safer, as these innovations provide effective solutions that can adapt to various environments and operational constraints. The increased prevalence of infectious disease outbreaks, including the COVID-19 pandemic, has also underscored the importance of bio decontamination in public spaces, leading to higher demand from sectors such as transportation, hospitality, retail, and government facilities. As consumers become more aware of hygiene and safety, they are more inclined to support businesses that prioritize bio decontamination, further driving market expansion. Collectively, these drivers are propelling the bio decontamination market forward, solidifying its role as a critical component in global efforts to maintain health, safety, and regulatory compliance across a wide range of industries.

SCOPE OF STUDY:

The report analyzes the Bio Decontamination market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product & Service (Equipment, Services, Consumables); End-Use (Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations, Hospitals & Healthcare Facilities)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 42 Featured) -

  • Amira S.r.l
  • ClorDiSys Solutions, Inc.
  • Ecolab
  • Fedegari Autoclavi SpA
  • Howorth Air Technology Ltd.
  • JCE Biotechnology
  • Noxilizer, Inc.
  • STERIS PLC
  • TOMI Environmental Solutions Inc.
  • Wenzhou Weike Biological Laboratory Equipment Co. Ltd.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Global Economic Update
    • Bio Decontamination - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Awareness of Infection Control Drives Growth in Bio Decontamination Market
    • Increasing Use of Bio Decontamination in Healthcare Expands Demand for Effective Solutions
    • Here's How Advances in Decontamination Technologies Enhance Efficacy Against Pathogens
    • Growing Focus on Patient Safety Supports Adoption of Bio Decontamination in Hospitals
    • Rising Demand for Chemical-Free Decontamination Fuels Use of UV and Vapor-Based Solutions
    • Here's How Automation in Decontamination Systems Reduces Labor Costs and Human Error
    • Focus on Minimizing Cross-Contamination Supports Demand for Routine Decontamination Protocols
    • Advancements in Portable Decontamination Devices Expand Applications Beyond Healthcare
    • Growing Demand for Decontamination Solutions in Pharmaceutical and Biotech Labs
    • Here's How Bio Decontamination Enhances Safety in Food Processing and Manufacturing
    • Rising Adoption of Remote Monitoring and Digital Controls Improves Decontamination Accuracy
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Bio Decontamination by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Bio Decontamination by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 3: World 15-Year Perspective for Bio Decontamination by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Equipment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Equipment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 6: World 15-Year Perspective for Equipment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 9: World 15-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 12: World 15-Year Perspective for Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Pharma & Medical Device Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Pharma & Medical Device Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 15: World 15-Year Perspective for Pharma & Medical Device Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Life Sciences & Biotech Research Organizations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Life Sciences & Biotech Research Organizations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 18: World 15-Year Perspective for Life Sciences & Biotech Research Organizations by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Hospitals & Healthcare Facilities by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Hospitals & Healthcare Facilities by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 21: World 15-Year Perspective for Hospitals & Healthcare Facilities by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 22: World Bio Decontamination Market Analysis of Annual Sales in US$ for Years 2015 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Bio Decontamination Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Bio Decontamination by Product & Service - Equipment, Services and Consumables - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Bio Decontamination by Product & Service - Equipment, Services and Consumables Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 25: USA 15-Year Perspective for Bio Decontamination by Product & Service - Percentage Breakdown of Value Sales for Equipment, Services and Consumables for the Years 2015, 2025 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Bio Decontamination by End-Use - Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Bio Decontamination by End-Use - Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 28: USA 15-Year Perspective for Bio Decontamination by End-Use - Percentage Breakdown of Value Sales for Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Bio Decontamination by Product & Service - Equipment, Services and Consumables - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Bio Decontamination by Product & Service - Equipment, Services and Consumables Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 31: Canada 15-Year Perspective for Bio Decontamination by Product & Service - Percentage Breakdown of Value Sales for Equipment, Services and Consumables for the Years 2015, 2025 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Bio Decontamination by End-Use - Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Bio Decontamination by End-Use - Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 34: Canada 15-Year Perspective for Bio Decontamination by End-Use - Percentage Breakdown of Value Sales for Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities for the Years 2015, 2025 & 2030
  • JAPAN
    • Bio Decontamination Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Bio Decontamination by Product & Service - Equipment, Services and Consumables - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Bio Decontamination by Product & Service - Equipment, Services and Consumables Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 37: Japan 15-Year Perspective for Bio Decontamination by Product & Service - Percentage Breakdown of Value Sales for Equipment, Services and Consumables for the Years 2015, 2025 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Bio Decontamination by End-Use - Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Bio Decontamination by End-Use - Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 40: Japan 15-Year Perspective for Bio Decontamination by End-Use - Percentage Breakdown of Value Sales for Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities for the Years 2015, 2025 & 2030
  • CHINA
    • Bio Decontamination Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for Bio Decontamination by Product & Service - Equipment, Services and Consumables - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Bio Decontamination by Product & Service - Equipment, Services and Consumables Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 43: China 15-Year Perspective for Bio Decontamination by Product & Service - Percentage Breakdown of Value Sales for Equipment, Services and Consumables for the Years 2015, 2025 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Bio Decontamination by End-Use - Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Bio Decontamination by End-Use - Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 46: China 15-Year Perspective for Bio Decontamination by End-Use - Percentage Breakdown of Value Sales for Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities for the Years 2015, 2025 & 2030
  • EUROPE
    • Bio Decontamination Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Bio Decontamination by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Bio Decontamination by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 49: Europe 15-Year Perspective for Bio Decontamination by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Bio Decontamination by Product & Service - Equipment, Services and Consumables - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Bio Decontamination by Product & Service - Equipment, Services and Consumables Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 52: Europe 15-Year Perspective for Bio Decontamination by Product & Service - Percentage Breakdown of Value Sales for Equipment, Services and Consumables for the Years 2015, 2025 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Bio Decontamination by End-Use - Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Bio Decontamination by End-Use - Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 55: Europe 15-Year Perspective for Bio Decontamination by End-Use - Percentage Breakdown of Value Sales for Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities for the Years 2015, 2025 & 2030
  • FRANCE
    • Bio Decontamination Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for Bio Decontamination by Product & Service - Equipment, Services and Consumables - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Bio Decontamination by Product & Service - Equipment, Services and Consumables Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 58: France 15-Year Perspective for Bio Decontamination by Product & Service - Percentage Breakdown of Value Sales for Equipment, Services and Consumables for the Years 2015, 2025 & 2030
    • TABLE 59: France Recent Past, Current & Future Analysis for Bio Decontamination by End-Use - Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Bio Decontamination by End-Use - Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 61: France 15-Year Perspective for Bio Decontamination by End-Use - Percentage Breakdown of Value Sales for Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities for the Years 2015, 2025 & 2030
  • GERMANY
    • Bio Decontamination Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Bio Decontamination by Product & Service - Equipment, Services and Consumables - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Bio Decontamination by Product & Service - Equipment, Services and Consumables Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 64: Germany 15-Year Perspective for Bio Decontamination by Product & Service - Percentage Breakdown of Value Sales for Equipment, Services and Consumables for the Years 2015, 2025 & 2030
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Bio Decontamination by End-Use - Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Bio Decontamination by End-Use - Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 67: Germany 15-Year Perspective for Bio Decontamination by End-Use - Percentage Breakdown of Value Sales for Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Bio Decontamination by Product & Service - Equipment, Services and Consumables - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Bio Decontamination by Product & Service - Equipment, Services and Consumables Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 70: Italy 15-Year Perspective for Bio Decontamination by Product & Service - Percentage Breakdown of Value Sales for Equipment, Services and Consumables for the Years 2015, 2025 & 2030
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Bio Decontamination by End-Use - Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Bio Decontamination by End-Use - Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 73: Italy 15-Year Perspective for Bio Decontamination by End-Use - Percentage Breakdown of Value Sales for Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Bio Decontamination Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for Bio Decontamination by Product & Service - Equipment, Services and Consumables - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Bio Decontamination by Product & Service - Equipment, Services and Consumables Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 76: UK 15-Year Perspective for Bio Decontamination by Product & Service - Percentage Breakdown of Value Sales for Equipment, Services and Consumables for the Years 2015, 2025 & 2030
    • TABLE 77: UK Recent Past, Current & Future Analysis for Bio Decontamination by End-Use - Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Bio Decontamination by End-Use - Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 79: UK 15-Year Perspective for Bio Decontamination by End-Use - Percentage Breakdown of Value Sales for Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 80: Rest of Europe Recent Past, Current & Future Analysis for Bio Decontamination by Product & Service - Equipment, Services and Consumables - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Rest of Europe Historic Review for Bio Decontamination by Product & Service - Equipment, Services and Consumables Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 82: Rest of Europe 15-Year Perspective for Bio Decontamination by Product & Service - Percentage Breakdown of Value Sales for Equipment, Services and Consumables for the Years 2015, 2025 & 2030
    • TABLE 83: Rest of Europe Recent Past, Current & Future Analysis for Bio Decontamination by End-Use - Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Rest of Europe Historic Review for Bio Decontamination by End-Use - Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 85: Rest of Europe 15-Year Perspective for Bio Decontamination by End-Use - Percentage Breakdown of Value Sales for Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Bio Decontamination Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 86: Asia-Pacific Recent Past, Current & Future Analysis for Bio Decontamination by Product & Service - Equipment, Services and Consumables - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Asia-Pacific Historic Review for Bio Decontamination by Product & Service - Equipment, Services and Consumables Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 88: Asia-Pacific 15-Year Perspective for Bio Decontamination by Product & Service - Percentage Breakdown of Value Sales for Equipment, Services and Consumables for the Years 2015, 2025 & 2030
    • TABLE 89: Asia-Pacific Recent Past, Current & Future Analysis for Bio Decontamination by End-Use - Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Asia-Pacific Historic Review for Bio Decontamination by End-Use - Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 91: Asia-Pacific 15-Year Perspective for Bio Decontamination by End-Use - Percentage Breakdown of Value Sales for Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities for the Years 2015, 2025 & 2030
  • REST OF WORLD
    • TABLE 92: Rest of World Recent Past, Current & Future Analysis for Bio Decontamination by Product & Service - Equipment, Services and Consumables - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of World Historic Review for Bio Decontamination by Product & Service - Equipment, Services and Consumables Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 94: Rest of World 15-Year Perspective for Bio Decontamination by Product & Service - Percentage Breakdown of Value Sales for Equipment, Services and Consumables for the Years 2015, 2025 & 2030
    • TABLE 95: Rest of World Recent Past, Current & Future Analysis for Bio Decontamination by End-Use - Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of World Historic Review for Bio Decontamination by End-Use - Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 97: Rest of World 15-Year Perspective for Bio Decontamination by End-Use - Percentage Breakdown of Value Sales for Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities for the Years 2015, 2025 & 2030

IV. COMPETITION